Testimonials from either docs or patients are meaningless at this point. Letters from shareholders are even more so. Only revised positions by the FDA will have any real impact.
Maligning the FDA and the SEC is just stupid. They may not always be right but, on the other hand, they are neither crazy nor malevolent.
So if Jellybean dismisses it, well just consider the letter ....